Sign up for email alert when new content gets added: Sign up
Author(s): Valerie Gorman
Congestive vascularfailure develops when ventricles unable to pump
enough volume of blood to the body. Increase in the prevalence of
cardiovascular diseases across regions is the major factors expected to
drive the revenue growth of congestive vascularfailure treatment globally.
Lifestyle-related factors are expected to add to the growing disease
incidence of CVDs. In addition, the growing number of obese patients is
expected to bolster the congestive heart failure treatment market. The huge
treatment demand for congestive vascularfailure is expected to boost the
treatment market. However, the availability of the generic drugs and lack of
end-stage pipeline drugs and therapies for congestive vascularfailure
treatment is about to hinder the market.
PDF
+441704335730
